Learn to Return

Your trusted resource for the design and implementation of customized COVID-19 testing strategies for Washington K-12 schools.



On November 2, the CDC voted unanimously to recommend Pfizer’s COVID-19 vaccine for children between the ages of 5-11.



Nov 22 Newsletter


Introducing the L2R Impact Fund!

Also featuring:

Learning Network insights on contact tracing

Pediatric vaccine updates

New Swab & Jab episode


Menu of TEsts

We offer a range of solutions to meet your testing needs. Explore the menu to learn about vendors and each type of test available for L2R schools.


Educator vaccination requirement & mask mandate

On August 18, 2021, Gov. Jay Inslee announced a vaccine requirement for employees working in education, as well as an expansion of the statewide mask mandate to all individuals, regardless of vaccination status. 

Host a school-based vaccination event!

Learn how school districts can help drive vaccine uptake in Washington communities.

School testing funded through July 2022!

Summer 2021 is a great time to launch, scale, or adapt testing strategies for fall 2021. 

Vaccines & Testing

Learn why vaccines & testing are the dynamic duo that will help schools open and stay open this fall with confidence.

Resources and Information

Menu of Tests

A quick guide to available L2R testing options

Testing FAQs

Answering key questions about L2R testing strategies for parents, guardians and families

Vaccine FAQS

Learn more about the vaccines & why you should get vaccinated

Vaccine & Testing FAQs

Learn why vaccines & testing are the dynamic duo that will help schools open and stay open this fall with confidence

School-Based Vax Events

Washington schools can take the lead in supporting vaccine uptake in communities by hosting vaccination events during the 2021 school year!

By the numbers

A summary of top testing vendor data between March 1 and September 1, 2021.

School districts engaged with L2R

School-based testing kick-off meetings held

Testing programs launched

Tests completed with a 5.83% positivity rate